Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on September 22, 2025
September 22, 2025
Lu Alleruzzo Steps Down as CEO of Immunophotonics After 15 Years, Leadership Transition to New CEO & President Announced
Indeterminate
EIN Presswire
September 22, 2025
ProHance Global Benchmarking Report H1’2025 Reveals Hybrid Models Drive Higher Productivity than Office-Only Setups
Indeterminate
EIN Presswire
September 22, 2025
ScribeEMR Presents AI Scribing, and Coding at NRHA
Indeterminate
EIN Presswire
September 22, 2025
Allergy Immunotherapy Market is growing at a CAGR of 10.4% from 2024 to 2033
Indeterminate
EIN Presswire
September 22, 2025
Cell Counting Market is generate $16.3 billion by 2032, witnessing a CAGR of 7.7%
Indeterminate
EIN Presswire
September 22, 2025
Operating Room Management Market to generate $10.0 billion by 2031, manifesting a CAGR of 13.0%
Indeterminate
EIN Presswire
September 22, 2025
Nasal Spray Market growing at a CAGR of 6.2% from 2022 to 2031
Indeterminate
EIN Presswire
September 22, 2025
ESG The Report Debuts Toolkits to Simplify ESG Reporting for Small Businesses
Indeterminate
EIN Presswire
September 22, 2025
Electron Beam Physical Vapor Deposition Coating Market is Likely to Enjoy Remarkable Growth by 2027
Indeterminate
EIN Presswire
September 22, 2025
APA Statement on White House Announcement on Autism
Indeterminate
GlobeNewswire
September 22, 2025
AMN Healthcare Announces Pricing of Senior Notes Offering
Indeterminate
GlobeNewswire
September 22, 2025
Fortrea Appoints William Sharbaugh to Board of Directors
Indeterminate
GlobeNewswire
September 22, 2025
BetaGlue Therapeutics gibt die Ernennung von Alexis Peyroles zum neuen Chief Executive Officer bekannt
Indeterminate
GlobeNewswire
September 22, 2025
BetaGlue Therapeutics annonce la nomination d’Alexis Peyroles au poste de directeur général
Indeterminate
GlobeNewswire
September 22, 2025
MBX Biosciences Announces Proposed Public Offering
Indeterminate
GlobeNewswire
September 22, 2025
GENFIT Reports First-Half 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
September 22, 2025
Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update
Indeterminate
GlobeNewswire
September 22, 2025
ArriVent Appoints Brent S. Rice as Chief Commercial Officer
Indeterminate
GlobeNewswire
September 22, 2025
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform
Indeterminate
GlobeNewswire
September 22, 2025
Eupraxia Pharmaceuticals Announces Proposed Public Offering of Common Shares
Indeterminate
GlobeNewswire